FDA
approval
· 2025-01-29
FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for Teva Pharmaceuticals' generic olanzapine and fluoxetine combination product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OLANZAPINE AND FLUOXETINE (OLANZAPINE AND FLUOXETINE)